Clinical outcomes and prognostic factors of parameningeal rhabdomyosarcoma in children and adolescents: results of two consecutive protocols
Authors:
Open Access
- 1 July 2024
- journal article
- research article
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 13 (7) , 1086-1096
Abstract
Background: Parameningeal rhabdomyosarcoma (PM-RMS) accounts for about 20% of all rhabdomyosarcoma (RMS) cases. At present, most research on PM-RMS has been conducted in Europe and the United States of America, and research in China has been very limited. This study sought to analyze the clinical outcomes and prognostic factors of PM-RMS in children and adolescents from two consecutive protocols at Beijing Children’s Hospital (BCH). Methods: A total of 80 patients aged up to 18 years with previously untreated PM-RMS who had received treatment under two consecutive protocols [i.e., either the BCH-RMS-2006 protocol or the Chinese Children Cancer Group (CCCG)-RMS-2016 protocol] were included in the statistical analysis. The Kaplan-Meier method was used for the survival analysis, and Cox regression was used for the univariate and multivariate analyses. Results: Of the 80 patients enrolled in the study, 69 (86.2%) had meningeal invasion (MI). Of these 69 MI patients, 18 (22.5%) had cranial nerve palsy (CNP), 64 (80.0%) had cranial base bone erosion (CBBE), 25 (31.3%) had intracranial extension (ICE), and 2 (2.5%) had positive cerebrospinal fluid (CSF) tumor cells. The median follow-up time was 20.5 months (range, 5–100 months). The 5-year overall survival (OS) and progression-free survival (PFS) rates for the entire cohort were 51.7% and 45.6%, respectively. The 5-year OS rates of the patients who received the BCH-RMS-2006 protocol (18/80, 22.5%) and the CCCG-RMS-2016 protocol (62/80, 77.5%) were 33.3% and 57.0%, respectively (PConclusions: Of the patients examined in this study, those with PM-RMS with CBBE accompanied by ICE had the worst prognosis. The patients with MI benefited from intensive chemotherapy combined with radiation therapy, but the effect of surgery was very limited.Keywords
This publication has 19 references indexed in Scilit:
- Surgical Interventions for Advanced Parameningeal Rhabdomyosarcoma of Children and AdolescentsCureus, 2018
- [Recommendations for the diagnosis and treatment of rhabdomyosarcoma in Chinese children and adolescents(CCCG-RMS-2016)].2017
- The impact of radiotherapy on clinical outcomes in parameningeal rhabdomyosarcomaRadiation Oncology Journal, 2016
- Local Failure in Parameningeal Rhabdomyosarcoma Correlates With Poor Response to Induction ChemotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groupsAnnals of Oncology, 2014
- The Effect of Radiation Timing on Patients With High-Risk Features of Parameningeal Rhabdomyosarcoma: An Analysis of IRS-IV and D9803International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Parameningeal Rhabdomyosarcoma: Outcomes and OpportunitiesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IVInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Treatment of children and adolescents with localized parameningeal sarcoma: Experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS‐II through ‐IV, 1978–1997*†Medical and Pediatric Oncology, 2001
- Parameningeal rhabdomyosarcoma: Results of an International WorkshopInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996